Literature DB >> 3179444

Development of the human coagulation system in the healthy premature infant.

M Andrew1, B Paes, R Milner, M Johnston, L Mitchell, D M Tollefsen, V Castle, P Powers.   

Abstract

This study was designed to determine the postnatal development of the human coagulation system in the healthy premature infant. Consecutive mothers of healthy premature infants born at either St Joseph's Hospital or McMaster University Medical Centre in Hamilton were asked for consent. One hundred thirty-seven premature infants (30 to 36 weeks of gestational age) entered the study. The premature infants did not have any major health problems and did not require ventilation or supplemental oxygen. Demographic information and a 20-mL blood sample were obtained in the postnatal period on days 1, 5, 30, 90, and 180. Between 40 and 96 premature infants were studied on each day for each of the following tests: prothrombin time, activated partial thromboplastin time, thrombin clotting time, plasminogen; 13 factor assays [fibrinogen, II, V, VII, VIII, IX, X, XI, XII, XIII, high-mol-wt kininogen (HMWK), prekallikrein (PK), von Willebrand factor (vWF)] and eight inhibitors [antithrombin III (AT-III), heparin cofactor II, alpha 2-antiplasmin, alpha 2-macroglobulin, alpha 1-antitrypsin, C1 esterase inhibitor, protein C (PC), and protein S (PS)]. A combination of biologic and immunologic assays were used. Between 30 to 36 weeks there was a minimal effect of gestational age for levels of AT-III, PC, and factors II and X only; therefore, the entire data set was used to generate reference ranges for these components of the coagulation system for premature infants. Next, the results for the premature infants were compared with those of a previously published study in 118 fullterm infants and with those for adults. An effect of gestational age was shown for plasminogen, fibrinogen, factors II, V, VIII, IX, XI, XII, HMWK, and all eight inhibitors. In general, the postnatal maturation towards adult levels was accelerated in premature infants as compared with the fullterm infants. By 6 months of age, most components of the coagulation system in premature infants had achieved near adult values.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3179444

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  76 in total

1.  Activation of the L-arginine nitric oxide pathway in severe sepsis.

Authors:  T Duke; M South; A Stewart
Journal:  Arch Dis Child       Date:  1997-03       Impact factor: 3.791

Review 2.  Anticoagulation in the young.

Authors:  Paul Monagle
Journal:  Heart       Date:  2004-07       Impact factor: 5.994

Review 3.  Neonatal transfusion practice.

Authors:  N A Murray; I A G Roberts
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-03       Impact factor: 5.747

Review 4.  Recommendations for transfusion therapy in neonatology.

Authors:  Gabriella Girelli; Stefano Antoncecchi; Anna Maria Casadei; Antonio Del Vecchio; Paola Isernia; Mario Motta; Daniela Regoli; Costantino Romagnoli; Gino Tripodi; Claudio Velati
Journal:  Blood Transfus       Date:  2015-07       Impact factor: 3.443

Review 5.  The neonatal coagulation system and the vitamin K deficiency bleeding - a mini review.

Authors:  Ewald Pichler; Ludwig Pichler
Journal:  Wien Med Wochenschr       Date:  2008

6.  Fibrin Network Changes in Neonates after Cardiopulmonary Bypass.

Authors:  Ashley C Brown; Riley T Hannan; Lucas H Timmins; Janet D Fernandez; Thomas H Barker; Nina A Guzzetta
Journal:  Anesthesiology       Date:  2016-05       Impact factor: 7.892

Review 7.  Renal vascular thrombosis in the newborn.

Authors:  Lourdes Paula R Resontoc; Hui-Kim Yap
Journal:  Pediatr Nephrol       Date:  2015-07-15       Impact factor: 3.714

8.  Developmental changes in circulating IL-8/CXCL8 isoforms in neonates.

Authors:  Akhil Maheshwari; Nikolai N Voitenok; Svetlana Akalovich; Sadiq S Shaik; David A Randolph; Brian Sims; Rakesh P Patel; Cheryl R Killingsworth; Michael B Fallon; Robin K Ohls
Journal:  Cytokine       Date:  2009-02-15       Impact factor: 3.861

9.  [Regional anesthesia procedures in childhood: Austrian interdisciplinary recommendations on pediatric perioperative pain management].

Authors:  B Messerer; M Platzer; C Justin; M Vittinghoff
Journal:  Schmerz       Date:  2014-02       Impact factor: 1.107

Review 10.  Anticoagulation therapy in children.

Authors:  Milind D Ronghe; Christina Halsey; Nicholas J Goulden
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.